Publications by authors named "Anne Dekeyne"

Claim this Profile
D
Dual-acting agents for improving cognition and real-world function in Alzheimer's disease: Focus on 5-HT6 and D3 receptors as hubs.
Mark J Millan, Anne Dekeyne, Alain Gobert, Mauricette Brocco, Clotilde Mannoury la Cour

Neuropharmacology· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Pro-cognitive and Neurochemical Profiles of Glycine Modulatory Site Agonists and Glycine Reuptake Inhibitors in the Rat: Potential Relevance to Cognitive Dysfunction and Its Management.
Kevin C F Fone, David J G Watson, Rodolphe I Billiras, Dorothee I Sicard, Anne Dekeyne

Mol Neurobiol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia.
Julie Meffre, Séverine Chaumont-Dubel, Clotilde Mannoury la Cour, Florence Loiseau, David J G Watson, Anne Dekeyne

EMBO Mol Med· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
Mark J Millan, Clotilde Mannoury la Cour, Benjamin Chanrion, Delphine S Dupuis, Benjamin Di Cara, Anne Dekeyne

J Pharmacol Exp Ther· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: II. A behavioral, neurochemical, and electrophysiological characterization.
Anne Dekeyne, Mauricette Brocco, Florence Loiseau, Alain Gobert, Jean-Michel Rivet

J Pharmacol Exp Ther· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Agomelatine suppresses locomotor hyperactivity in olfactory bulbectomised rats: a comparison to melatonin and to the 5-HT(2c) antagonist, S32006.
Trevor R Norman, Ingrid Cranston, Jeremy A Irons, Cecilia Gabriel, Anne Dekeyne

Eur J Pharmacol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S41744, a dual neurokinin (NK)1 receptor antagonist and serotonin (5-HT) reuptake inhibitor with potential antidepressant properties: a comparison to aprepitant (MK869) and paroxetine.
Mark J Millan, Anne Dekeyne, Alain Gobert, Clotilde Mannoury la Cour, Mauricette Brocco

Eur Neuropsychopharmacol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discriminative stimulus properties of the atypical antidepressant, mirtazapine, in rats: a pharmacological characterization.
Anne Dekeyne, Mark J Millan

Psychopharmacology (Berl)· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurokinin1 antagonists potentiate antidepressant properties of serotonin reuptake inhibitors, yet blunt their anxiogenic actions: a neurochemical, electrophysiological, and behavioral characterization.
Alain Gobert, Mauricette Brocco, Anne Dekeyne, Benjamin Di Cara, Gaëlle Bouchez

Neuropsychopharmacology· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The melanin-concentrating hormone1 receptor antagonists, SNAP-7941 and GW3430, enhance social recognition and dialysate levels of acetylcholine in the frontal cortex of rats.
Mark J Millan, Alain Gobert, Fany Panayi, Jean-Michel Rivet, Anne Dekeyne

Int J Neuropsychopharmacol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular and behavioural profile of the novel, selective neurokinin1 receptor antagonist, vestipitant: a comparison to other agents.
Mauricette Brocco, Anne Dekeyne, Clotilde Mannoury la Cour, Manuelle Touzard, Sylvie Girardon

Eur Neuropsychopharmacol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models.
Anne Dekeyne, Clotilde Mannoury la Cour, Alain Gobert, Mauricette Brocco, Françoise Lejeune

Psychopharmacology (Berl)· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S33138 (N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1] benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenyl-acetamide), a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: III. Actions in models of therapeutic activity and induction of side effects.
Mark J Millan, Florence Loiseau, Anne Dekeyne, Alain Gobert, Gunnar Flik

J Pharmacol Exp Ther· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent. II. A neurochemical, electrophysiological and behavioral characterization in vivo.
Mark J Millan, Per Svenningsson, Charles R Ashby, Michael Hill, Martin Egeland, Anne Dekeyne

J Pharmacol Exp Ther· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pro-cognitive effects of 5-HT6 receptor antagonists in the social recognition procedure in rats: implication of the frontal cortex.
Florence Loiseau, Anne Dekeyne, Mark J Millan

Psychopharmacology (Berl)· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats: a characterization with alpha/beta-adrenoceptor subtype selective ligands, antidepressants, and antagonists at neuropeptide receptors.
Mark J Millan, Anne Dekeyne

Int J Neuropsychopharmacol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of dopamine D1 receptors enhances cholinergic transmission and social cognition: a parallel dialysis and behavioural study in rats.
Benjamin Di Cara, Fany Panayi, Alain Gobert, Anne Dekeyne, Dorothée Sicard

Int J Neuropsychopharmacol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discriminative stimulus properties of S32504, a novel D3/D2 receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox, N-desmethylclozapine, and by selective antagonists at dopamine D2 but not D3 receptors.
Mark J Millan, Loretta Iob, Jean-Louis Péglion, Anne Dekeyne

Psychopharmacology (Berl)· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective blockade of dopamine D(3) versus D(2) receptors enhances frontocortical cholinergic transmission and social memory in rats: a parallel neurochemical and behavioural analysis.
Mark J Millan, Benjamin Di Cara, Anne Dekeyne, Fany Panayi, Lotte De Groote

J Neurochem· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
Mauricette Brocco, Anne Dekeyne, Mariusz Papp, Mark J Millan

Behav Pharmacol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discriminative stimulus properties of the selective and highly potent alpha2-adrenoceptor agonist, S18616, in rats: mediation by the alpha2A subtype, and blockade by the atypical antidepressants, mirtazapine and mianserin.
Anne Dekeyne, Mark J Millan

Neuropharmacology· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Behavioural models for the characterisation of established and innovative antidepressant agents.
Anne Dekeyne

Therapie· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade.
Mark J Millan, Mauricette Brocco, Alain Gobert, Anne Dekeyne

Psychopharmacology (Berl)· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The serotonin1A receptor partial agonist S15535 [4-(benzodioxan-5-yl)1-(indan-2-yl)piperazine] enhances cholinergic transmission and cognitive function in rodents: a combined neurochemical and behavioral analysis.
Mark J Millan, Alain Gobert, Sylvain Roux, Roger Porsolt, Alfredo Meneses, Anne Dekeyne

J Pharmacol Exp Ther· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: III. Actions in models of potential antidepressive and anxiolytic activity in comparison with ropinirole.
Mark J Millan, Mauricette Brocco, Mariusz Papp, Florence Serres, Christophe Drieu La Rochelle, Anne Dekeyne

J Pharmacol Exp Ther· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis